| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/24/1993 | EP0527788A1 Hepatitis c virus protease |
| 02/24/1993 | EP0527785A1 Improvements relating to the detection of viruses |
| 02/24/1993 | EP0527783A1 Method of treatment with hsp70 |
| 02/24/1993 | EP0527781A1 Methods and formulations for stabilizing fibroblast growth factor |
| 02/24/1993 | EP0527774A1 Calcitonin gene related peptide for the treatment of undescended testicles |
| 02/24/1993 | EP0527771A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | EP0527761A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | EP0527755A1 Improved method for radiolabeling monovalent antibody fragments |
| 02/24/1993 | EP0502949A4 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same |
| 02/24/1993 | CA2076619A1 2-piperazinone compounds, their production and use |
| 02/23/1993 | WO1993004090A1 Hiv immunotherapeutics |
| 02/23/1993 | WO1993003741A1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
| 02/23/1993 | US5189204 Optical active 3-(2-trifluoro-1-hydroxyethyl) propenyl benzyl ether, derivatives thereof, method for preparing the same and use thereof for liquid crystal compound |
| 02/23/1993 | US5189178 Preventing protein destruction |
| 02/23/1993 | US5189149 High concentration, solvent-free |
| 02/23/1993 | US5189148 Fibroblast growth factor; mixture with water insoluble hydroxypropyl cellulose |
| 02/23/1993 | US5189146 Pasteurizable, freeze-driable hemoglobin-based blood substitute |
| 02/23/1993 | US5189064 Treatment of cocaine addiction |
| 02/23/1993 | US5189050 Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder |
| 02/23/1993 | US5189023 Hypotensive agent |
| 02/23/1993 | US5189022 Using polypeptide |
| 02/23/1993 | US5189021 Administering LH-RH analog peptide |
| 02/23/1993 | US5189020 Method of reducing neuronal damage using omega conotoxin peptides |
| 02/23/1993 | US5189019 Antistasin derived anticoagulant protein |
| 02/23/1993 | US5189018 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma |
| 02/23/1993 | US5189014 Administering a dose of one Fc reagent selected from exogenous polypeptide having atleast one site binds to the Fc-portion of said antigen-antibody immune complex being susceptible to such binding; immunotherapy |
| 02/23/1993 | US5188943 Method of producing high molecular weight human fibroblast growth factors |
| 02/23/1993 | US5188933 Dna sequences coding protein having immunosuppressant activity |
| 02/23/1993 | US5188830 Methods for thrombolytic therapy |
| 02/23/1993 | US5188828 Interleukin-6 to stimulate erythropoietin production |
| 02/23/1993 | US5188827 Use of interleukin-4- for lowering blood-cholesterol levels |
| 02/23/1993 | CA2076558A1 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes |
| 02/23/1993 | CA1313820C High titer anti-respiratory syncytial virus intravenous immune globulin |
| 02/21/1993 | CA2076505A1 Lps-containing anti-withdrawal agents |
| 02/20/1993 | CA2076321A1 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma |
| 02/18/1993 | WO1993003174A1 Tissue-selective insulin analogs |
| 02/18/1993 | WO1993003163A1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
| 02/18/1993 | WO1993003162A1 Ecdysteroid dependent regulation of genes in mammalian cells |
| 02/18/1993 | WO1993003152A1 Igf-ii analogues |
| 02/18/1993 | WO1993003148A2 Tau/neurofilament protein kinases pk40 and pk36 |
| 02/18/1993 | WO1993003146A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | WO1993003140A1 Improvement of the regeneration of oligodendrocytes |
| 02/18/1993 | WO1993003060A1 Amide derivatives of antibiotic a 40926 |
| 02/18/1993 | WO1993003059A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 02/18/1993 | WO1993003058A2 NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
| 02/18/1993 | WO1993003056A1 Lanthionine bridged peptides |
| 02/18/1993 | WO1993003055A1 Peptide compounds inhibiting hiv adsorption on target cells |
| 02/18/1993 | WO1993003054A1 Novel tetrapeptide derivative |
| 02/18/1993 | WO1993003050A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | WO1993003048A1 Process for purifying pentostatin |
| 02/18/1993 | WO1993003037A1 Organic nitrates, methods for preparing same and use thereof for treating cardiovascular diseases |
| 02/18/1993 | WO1993003035A1 Anti-hiv drug |
| 02/18/1993 | WO1993002708A1 Novel reagent for tumour imaging and therapy |
| 02/18/1993 | WO1993002705A1 Method for inhibiting blood coagulant activity |
| 02/18/1993 | WO1993002702A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/18/1993 | WO1993002701A1 Buffered formulation of peg-sod |
| 02/18/1993 | WO1993002700A1 Use of collagen for the prophylaxis of herpes labialis infections |
| 02/18/1993 | WO1993002699A1 Use of collagen for the treatment of degenerative joint ailments |
| 02/18/1993 | WO1993002698A1 Monoclonal antibodies to leukocyte adhesion molecule-1 |
| 02/18/1993 | WO1993002696A1 T-cell membrane protein for b cell ig class switching |
| 02/18/1993 | WO1993002695A1 Igf-1 to improve the neural condition |
| 02/18/1993 | WO1993002694A1 Retinol-binding receptor and complex |
| 02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 02/18/1993 | WO1993002692A1 Method of combatting hiv infections |
| 02/18/1993 | WO1993002691A1 Steroid hormone drug delivery |
| 02/18/1993 | WO1993002690A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | WO1993002689A1 Synthetic ribonucleases and methods for preparing and using same |
| 02/18/1993 | WO1993002679A1 Method of treating premenstrual syndrome by administration of an angiotensin converting enzyme inhibitor |
| 02/18/1993 | WO1993002667A1 Pharmaceutical composition |
| 02/18/1993 | WO1993002664A1 W/o microemulsions |
| 02/18/1993 | WO1993002662A1 Antiviral pharmaceutical compositions for vaginal administration |
| 02/18/1993 | WO1992014696A3 SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES |
| 02/18/1993 | CA2115246A1 Lanthionine bridged peptides |
| 02/18/1993 | CA2114942A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | CA2114647A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | CA2114240A1 Buffered formulation of peg-sod |
| 02/18/1993 | CA2114216A1 Antiviral pharmaceutical compositions for vaginal administration |
| 02/18/1993 | CA2114141A1 W/o microemulsions |
| 02/18/1993 | CA2113922A1 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 02/18/1993 | CA2113837A1 Anti-hiv agent |
| 02/18/1993 | CA2113280A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | CA2112566A1 Non-desensitizing analogs of gnrh and other biologically active ligands |
| 02/18/1993 | CA2083273A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/17/1993 | EP0527624A2 Use of a selective inhibitor of neutral endopeptidase and an angiotensin converting enzyme inhibitor in the preparation of a pharmaceutical for treating congestive heart failure |
| 02/17/1993 | EP0527283A1 Food composition |
| 02/17/1993 | EP0527189A1 Novel cc-1065 analogs |
| 02/17/1993 | EP0453554A4 Chimeric mouse human antibodies with specificity to hiv antigens |
| 02/17/1993 | CN1068965A Implant compositions containing biologically active protein, peptide or polypeptide |
| 02/17/1993 | CA2076204A1 Hiv protease inhibitors with n-terminal polyether substituents |
| 02/17/1993 | CA2075678A1 Non-substrate inhibitors of farnesyl protein transferase |
| 02/17/1993 | CA2075662A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity |
| 02/16/1993 | US5187268 Gene encoding an anti-complement protein from vaccinia |
| 02/16/1993 | US5187263 Genetically engineered, platelet derived growth factor protein |
| 02/16/1993 | US5187195 Anthraquinone derivatives and preparation thereof |
| 02/16/1993 | US5187177 Method and a pharmaceutical preparation for treating pain |
| 02/16/1993 | US5187158 Brain-specific drug delivery |
| 02/16/1993 | US5187157 Peptide boronic acid inhibitors of trypsin-like proteases |
| 02/16/1993 | US5187156 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 02/16/1993 | US5187155 For inhibiting activation of Factor X |